loader
Please Wait
Applying Filters...

Annual Sales of Riociguat reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 43,291Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14Adempas

02 2Alliance revenue - Adempas/Verquvo

PharmaCompass

01

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 760

2019 Revenue in Millions : 506

Growth (%) : 50

blank

02

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 813

2020 Revenue in Millions : 760

Growth (%) : 18

blank

03

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 501

2019 Revenue in Millions : 419

Growth (%) : 20

blank

04

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 252

2020 Revenue in Millions : 220

Growth (%) : 15

blank

05

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 238

2021 Revenue in Millions : 252

Growth (%) : -6

blank

06

Brand Name : Alliance revenue - Adempas/Verquvo

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Alliance revenue - Adempas/Verquvo

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 341

2021 Revenue in Millions : 342

Growth (%) : -0.3

blank

07

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 685

2021 Revenue in Millions : 813

Growth (%) : -16

blank

08

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 716

2022 Revenue in Millions : 685

Growth (%) : 1

blank

09

Brand Name : Adempas

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Adempas

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 255

2022 Revenue in Millions : 238

Growth (%) : 7

blank

10

Brand Name : Alliance revenue - Adempas/Verquvo

Riociguat

arrow
Formnext Forum
Not Confirmed

Brand Name : Alliance revenue - Adempas/Verquvo

arrow
Formnext Forum
Not Confirmed

Riociguat

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 367

2022 Revenue in Millions : 341

Growth (%) : 7.6

blank